Dr. Pavel Hamet, MD, PhD

Claim this profile
Studies Cardiovascular Disease
Studies Diabetic Kidney Disease
1 reported clinical trial
1 drug studied

Clinical Trials Pavel Hamet, MD, PhD is currently running

Image of trial facility.

Genetic Test

for Cardiorenal Complications in Type 2 Diabetes

The goal of this pragmatic trial is to provide Real World Evidence (RWE) on the impact of the result of a polygenic risk prediction test of cardiorenal complications of T2D, so that more patients at high risk of these complications achieve over an 18 months period, recommended therapeutic targets. This will be demonstrated as a significant improvement in a composite value including HbA1c or systolic blood pressure (SBP) or albuminuria (UACR), or glomerular filtration rate (GFR) lowering. Researchers will compare the recommended therapeutic targets of uninformed and informed patients to see if the knowledge of the risk by the patients and their treating physicians improves achievement of these targets. Participants will: Have a saliva sampling to determine the genetic risk. Visit the clinic once every 3 months for checkups and tests Answer two questionnaires on quality of life.
Recruiting1 award N/A1 criteria

More about Pavel Hamet, MD, PhD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Pavel Hamet, MD, PhD has experience with
  • Polygenic Risk Score
Breakdown of trials Pavel Hamet, MD, PhD has run
Cardiovascular Disease
Diabetic Kidney Disease
Sleep Apnea and Cardiovascular Disease
Diabetes Mellitus
Hypertension

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Pavel Hamet, MD, PhD specialize in?
Pavel Hamet, MD, PhD focuses on Cardiovascular Disease and Diabetic Kidney Disease. In particular, much of their work with Cardiovascular Disease has involved treating patients, or patients who are undergoing treatment.
Is Pavel Hamet, MD, PhD currently recruiting for clinical trials?
Yes, Pavel Hamet, MD, PhD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Pavel Hamet, MD, PhD has studied deeply?
Yes, Pavel Hamet, MD, PhD has studied treatments such as Polygenic Risk Score.
What is the best way to schedule an appointment with Pavel Hamet, MD, PhD?
Apply for one of the trials that Pavel Hamet, MD, PhD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top